Sharpening the Future: New Opportunities for Implant Injection

October 1st, 2024 – 4pm (CET) / 10am (ET)

Gaplast-Homepage

Sharpening the Future: New Opportunities for Implant Injection

October 1st, 2024 – 4pm (CET) / 10am (ET)

Addressed Challenges

1) Drug Implant Technology

Advances in drug delivery through implants, technological

2) Safe Drug Application

Strategies for ensuring safe and effective drug application in implants

3) Market Situation

Current market trends, challenges, and opportunities in the medical implant industry

Learning Objectives

  • Opening up new markets for drug implants
  • Sustainability by using long acting drug device systems
  • Benefits of smart implant injection technology

Ingmar Kneer

Product Manager BU Drug Device Systems

Ingmar Kneer is a Product Manager at Gaplast GmbH, focusing on drug-device combination products. He has played a key role in developing innovative solutions like the implant syringe, enhancing subcutaneous drug administration. With a strong background in plastic engineering and medical device consulting, Ingmar's expertise drives advancements in drug delivery systems and strengthens Gaplast's position in the pharmaceutical industry.
Read More >>>

<span>By ticking this box, you consent to receiving communications from Gaplast related to this topic and other products or services within their portfolio</span>

Dark